ACM
DGX icon

Aviance Capital Management’s Quest Diagnostics DGX Stock Holding History

Aviance Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-5,332
Closed -$451K – 220
2016
Q3 		$451K Buy
5,332
+718
+16% +$60.3K 0.01% 263
2016
Q2 		$376K Buy
4,614
+273
+6% +$20.8K 0.01% 266
2016
Q1 		$310K Sell
4,341
-103
-2% -$6.91K 0.01% 259
2015
Q4 		$316K Buy
4,444
+309
+7% +$20.8K 0.01% 251
2015
Q3 		$254K Buy
+4,135
New +$289K 0.01% 272

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Aviance Capital Management's DGX Position: Q4 2016 in Review

Aviance Capital Management sold out of Quest Diagnostics (DGX) in Q4 2016, closing a stake of 5,332 shares — an estimated $451K sold.

Aviance Capital Management first reported a position in DGX in Q3 2015 and held it in 5 quarters. The position peaked at $451K in Q3 2016. 598 funds tracked by Wall St. Rank hold DGX as of Q4 2016.

  • Aviance Capital Management reported no remaining Quest Diagnostics position as of Q4 2016 after selling out during the quarter.
  • Aviance Capital Management sold 5,332 Quest Diagnostics shares in Q4 2016, an estimated $451K.
  • Aviance Capital Management first reported a position in Quest Diagnostics in Q3 2015 and held it in 5 quarters.
  • Aviance Capital Management's Quest Diagnostics position peaked at $451K in Q3 2016.
  • 598 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2016.

Based on Aviance Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.